Showing results (1-10 of 124) with videos related to
Sort By:
Pageof 13
Molecular & Cellular Oncology|June 17, 2016
Direct pharmacological assessment of clinically acquired models as a strategy to overcome resistance to tyrosine kinase inhibitorsCyril H BenesScience Signaling|September 26, 2013
Bypass mechanisms of resistance to receptor tyrosine kinase inhibition in lung cancerMatthew J Niederst, Jeffrey A EngelmanBMC Bioinformatics|February 20, 2019
Statistical assessment and visualization of synergies for large-scale sparse drug combination datasetsArnaud Amzallag, Sridhar Ramaswamy, Cyril H BenesBiochimica Et Biophysica Acta|March 15, 2011
P2X(7) receptor antagonists display agonist-like effects on cell signaling proteinsLee Hedden, Cyril H Benes, Stephen P SoltoffThe FEBS Journal|February 21, 2012
Suppression of survival signalling pathways by the phosphatase PHLPPAudrey K O'Neill, Matthew J Niederst, Alexandra C NewtonCancer Research|July 13, 2017
APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR InhibitionRémi Buisson, Michael S Lawrence, Cyril H Benes, et al.Molecular Cell|September 15, 2015
Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S PhaseRémi Buisson, Jessica L Boisvert, Cyril H Benes, et al.The Lancet. Oncology|April 8, 2015
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of originMatthew G Oser, Matthew J Niederst, Lecia V Sequist, et al.Science (New York, N.Y.)|June 29, 2019
Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic featuresRémi Buisson, Adam Langenbucher, Danae Bowen, et al.Pageof 13